CMI Following ABSCT in ML Patients Versus Historical Controls: Disease Characteristics
| . | CMI . | Nodular Sclerosis . | Histology . | Lymphocyte Depleted . | P . | Systemic Symptoms . | P . | ||
|---|---|---|---|---|---|---|---|---|---|
| . | . | . | Mixed Cellularity . | . | . | CMI . | A . | B . | . |
| HD | + | 19 | 5 | 0 | NS | HD+ | 5 | 19 | NS |
| − | 18 | 6 | 1 | − | 9 | 16 | |||
| Low Grade | |||||||||
| Intermediate | |||||||||
| Grades | |||||||||
| High Grade | |||||||||
| NHL | + | 9 | 16 | 7 | NS | NHL+ | 18 | 14 | NS |
| 3 | 20 | 13 | − | 15 | 21 | ||||
| . | CMI . | Nodular Sclerosis . | Histology . | Lymphocyte Depleted . | P . | Systemic Symptoms . | P . | ||
|---|---|---|---|---|---|---|---|---|---|
| . | . | . | Mixed Cellularity . | . | . | CMI . | A . | B . | . |
| HD | + | 19 | 5 | 0 | NS | HD+ | 5 | 19 | NS |
| − | 18 | 6 | 1 | − | 9 | 16 | |||
| Low Grade | |||||||||
| Intermediate | |||||||||
| Grades | |||||||||
| High Grade | |||||||||
| NHL | + | 9 | 16 | 7 | NS | NHL+ | 18 | 14 | NS |
| 3 | 20 | 13 | − | 15 | 21 | ||||
| CMI | I | Disease Stage | P | CMI | 1st CR | 2nd CR | Disease Status at BMT | ||||||
| II | III | IV | >2nd CR | PR | PD | P | |||||||
| HD | + | 0 | 6 | 12 | 6 | NS | HD+ | 0 | 7 | 4 | 8 | 5 | NS |
| − | 1 | 10 | 8 | 6 | − | 3 | 4 | 2 | 9 | 7 | |||
| NHL | + | 2 | 4 | 9 | 17 | NS | NHL+ | 8 | 6 | 2 | 13 | 3 | NS |
| − | 3 | 4 | 7 | 22 | − | 8 | 6 | 3 | 10 | 11 | |||
| CMI | I | Disease Stage | P | CMI | 1st CR | 2nd CR | Disease Status at BMT | ||||||
| II | III | IV | >2nd CR | PR | PD | P | |||||||
| HD | + | 0 | 6 | 12 | 6 | NS | HD+ | 0 | 7 | 4 | 8 | 5 | NS |
| − | 1 | 10 | 8 | 6 | − | 3 | 4 | 2 | 9 | 7 | |||
| NHL | + | 2 | 4 | 9 | 17 | NS | NHL+ | 8 | 6 | 2 | 13 | 3 | NS |
| − | 3 | 4 | 7 | 22 | − | 8 | 6 | 3 | 10 | 11 | |||
Abbreviations: 1st CR, first complete remission; 2nd CR, second complete remission; PR, partial response; PD, progressive disease.